BDBM503523 N-[(7S)-4-fluorobicyclo[4.2.0]octa- 1,3,5-trien-7-yl]-N'-hydroxy-4-{[1- (1H-1,2,4-triazole-3- carbonyl)azetidin-3-yl]oxy}-1,2,5- oxadiazole-3-carboximidamide::US11034661, Example 30

SMILES O=C(c1nc[nH]n1)N1CC(Oc2nonc2/C(=N/O)N[C@H]2Cc3ccc(F)cc32)C1

InChI Key InChIKey=UDJFQUVUYLGSIO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 503523   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 503523BDBM503523(N-[(7S)-4-fluorobicyclo[4.2.0]octa- 1,3,5-trien-7...)
Affinity DataIC50: 56nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 μM delta aminole...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2021
Entry Details
US Patent